EP1430302A4 - Glycosaminoglycans-hemmer - Google Patents

Glycosaminoglycans-hemmer

Info

Publication number
EP1430302A4
EP1430302A4 EP02728711A EP02728711A EP1430302A4 EP 1430302 A4 EP1430302 A4 EP 1430302A4 EP 02728711 A EP02728711 A EP 02728711A EP 02728711 A EP02728711 A EP 02728711A EP 1430302 A4 EP1430302 A4 EP 1430302A4
Authority
EP
European Patent Office
Prior art keywords
glycosaminoglycan
inhibitors
glycosaminoglycan inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02728711A
Other languages
English (en)
French (fr)
Other versions
EP1430302A2 (de
Inventor
Akira Takashima
Mark E Mummert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of EP1430302A2 publication Critical patent/EP1430302A2/de
Publication of EP1430302A4 publication Critical patent/EP1430302A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP02728711A 2001-03-21 2002-03-20 Glycosaminoglycans-hemmer Withdrawn EP1430302A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27779001P 2001-03-21 2001-03-21
US277790P 2001-03-21
PCT/US2002/011167 WO2002076173A2 (en) 2001-03-21 2002-03-20 Inhibitors of glycosaminoglycans

Publications (2)

Publication Number Publication Date
EP1430302A2 EP1430302A2 (de) 2004-06-23
EP1430302A4 true EP1430302A4 (de) 2007-08-22

Family

ID=23062353

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02728711A Withdrawn EP1430302A4 (de) 2001-03-21 2002-03-20 Glycosaminoglycans-hemmer

Country Status (5)

Country Link
EP (1) EP1430302A4 (de)
JP (1) JP2004532203A (de)
AU (1) AU2002258749A1 (de)
CA (1) CA2439409A1 (de)
WO (1) WO2002076173A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2720587A1 (en) 2008-04-09 2009-10-15 Francis Barany Coferons and methods of making and using them
US9771345B2 (en) 2009-10-07 2017-09-26 Cornell University Coferons and methods of making and using them
US9795686B2 (en) * 2012-01-19 2017-10-24 The Johns Hopkins University Biomaterials comprising hyaluronic acid binding peptides and bifunctional biopolymer molecules for hyaluronic acid retention and tissue engineering applications

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
EP0950708A2 (de) * 1997-12-19 1999-10-20 Cangene Corporation Peptide die Hyaluronan mit erhöter Affinität binden
WO2000057896A1 (en) * 1999-03-26 2000-10-05 The University Of Texas System Modulators of polysaccharides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643575A (en) * 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
CA2230385A1 (en) * 1995-09-05 1997-03-13 Cambridge Neuroscience, Inc. Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof
AU4971699A (en) * 1998-07-06 2000-01-24 Bai Luo Hyaluronic acid mimics and methods related thereto
WO2000068263A2 (en) * 1999-05-05 2000-11-16 Neurochem, Inc. Stereoselective antifibrillogenic peptides and peptidomimetics thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
EP0950708A2 (de) * 1997-12-19 1999-10-20 Cangene Corporation Peptide die Hyaluronan mit erhöter Affinität binden
WO2000057896A1 (en) * 1999-03-26 2000-10-05 The University Of Texas System Modulators of polysaccharides and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARRITHERS M D ET AL: "SYNTHESIS AND CHARACTERIZATION OF BIVALENT PEPTIDE LIGANDS TARGETED TO G-PROTEIN-COUPLED RECEPTORS", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, vol. 3, no. 5, May 1996 (1996-05-01), pages 537 - 542, XP000945385, ISSN: 1074-5521 *
MUMMERT M E ET AL: "Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.", THE JOURNAL OF EXPERIMENTAL MEDICINE 18 SEP 2000, vol. 192, no. 6, 18 September 2000 (2000-09-18), pages 769 - 779, XP009081295, ISSN: 0022-1007 *
TAKASHIMA A ET AL: "NEW TECHNOLOGIES TO PREVENT AND TREAT CONTACT HYPERSENSITIVITY RESPONSES", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US, vol. 919, 2000, pages 205 - 213, XP009060432, ISSN: 0077-8923 *

Also Published As

Publication number Publication date
CA2439409A1 (en) 2002-10-03
WO2002076173A2 (en) 2002-10-03
EP1430302A2 (de) 2004-06-23
AU2002258749A1 (en) 2002-10-08
JP2004532203A (ja) 2004-10-21
WO2002076173A3 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
PT1370553E (pt) Inibidores de rhoquinase
CY20162200002T2 (el) Αντιιικοι παραγοντες
DE60234125D1 (de) E inhibitoren
IS7890A (is) C-6 breytt indazólýlpýrrólótríazín
EP1560584A4 (de) Fab-i-inhibitoren
DE60214255D1 (de) Schlussstück
DE60229764D1 (de) Entgratwerkzeug
DE60104977D1 (de) Glucosamine enthaltende Neutrophilfunktionshemmer
ITMI20031187A1 (it) Astuccio per occhiali
EP1430302A4 (de) Glycosaminoglycans-hemmer
DE60201319D1 (de) Trisazoverbindung
EP1445063A4 (de) Werstückträger
ATE369083T1 (de) Befestigungsschraube
DE50202045D1 (de) Leitungsanordnung
FI20011441A0 (fi) Levitysjärjestely
AT500592B1 (de) Entstörgerät
ATA15542001A (de) Befestigungsanordnung
DE60237916D1 (de) Verdickungsmittel
NO20041687L (no) Sluttstykke
SE0103396D0 (sv) Glasögon
ITBO20010212A0 (it) Occhiali
ITBO20010087A0 (it) Occhiali
DOP2001000307A (es) Inhibidores de thrombin
ES1051079Y (es) Troqueladora oleo-neumatica de perfiles
UA7409S (uk) Стакан

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031014

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20070720

17Q First examination report despatched

Effective date: 20071115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080326